Physiologically‐Based Pharmacokinetic Modeling Approach to Predict Rifampin‐Mediated Intestinal P‐Glycoprotein Induction
Physiologically‐based pharmacokinetic (PBPK) modeling is a powerful tool to quantitatively describe drug disposition profiles in vivo, thereby providing an alternative to predict drug-drug interactions (DDIs) that have not been tested clinically. This study aimed to predict effects of rifampin‐media...
Saved in:
Main Authors: | Shinji Yamazaki (Author), Chester Costales (Author), Sarah Lazzaro (Author), Soraya Eatemadpour (Author), Emi Kimoto (Author), Manthena V. Varma (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2019-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Quantitative prediction of breast cancer resistant protein mediated drug‐drug interactions using physiologically‐based pharmacokinetic modeling
by: Chester Costales, et al.
Published: (2021) -
Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
by: Shinji Yamazaki, et al.
Published: (2022) -
Corrigendum to: Physiologically‐based pharmacokinetic modeling to evaluate in vitro‐to‐in vivo extrapolation for intestinal P‐glycoprotein inhibition
by: Shinji Yamazaki, et al.
Published: (2022) -
Unraveling pleiotropic effects of rifampicin by using physiologically based pharmacokinetic modeling: Assessing the induction magnitude of P‐glycoprotein-cytochrome P450 3A4 dual substrates
by: Xian Pan, et al.
Published: (2021) -
Robust physiologically based pharmacokinetic model of rifampicin for predicting drug-drug interactions via P‐glycoprotein induction and inhibition in the intestine, liver, and kidney
by: Ryuta Asaumi, et al.
Published: (2022)